1-[2-(substituted vinyl)]-3-4--dihydro-5h-2,3-benzodiazepine derivatives

The invention relates to new 1-[2-(substituted vinyl)]-3,4-dihydro-5+E,uns H+EE -2,3-benzodiazepine derivatives, a process for the preparation thereof and pharmaceutical compositions comprising them. The new 1-[2-(substituted vinyl)]-3,4-dihidro-5+E,uns H+EE -2,3-benzodiazepine derivatives according...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GYOERGYNE MATE, FERENC ANDRASI, IMRE MORAVCSIK, ESZTER SZENTKUTI, PAL VAGO, EDIT HORVATH, GYOERGY SOMOGYI, ANNA BAKONYI, GABOR ZOLYOMI, ERZSEBET BIRKAS FAIGLNE, TAMAS HAMORI, PETER BOTKA, GABOR GIGLER, JENO KOROSI, JOSZEF REITER, PAL BERZSENYI, KATALIN HORVATH, ISTVAN GYERTYAN
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to new 1-[2-(substituted vinyl)]-3,4-dihydro-5+E,uns H+EE -2,3-benzodiazepine derivatives, a process for the preparation thereof and pharmaceutical compositions comprising them. The new 1-[2-(substituted vinyl)]-3,4-dihidro-5+E,uns H+EE -2,3-benzodiazepine derivatives according to the invention correspond to the general formula (I), wherein the variables are hereinbelow defined: The new compounds according to the invention affect the central nervous system and can be used to advantage in the therapy.